Learn how PADCEV plus pembrolizumab reshapes first-line advanced urothelial cancer care—and how nurses spot and manage serious toxicities early.
Amanda Nizam, MD, Genitourinary Medical Oncologist, Cleveland Clinic
Advertisement
Articles by Amanda Nizam, MD, Genitourinary Medical Oncologist, Cleveland Clinic
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Perioperative Pembrolizumab-EV Regimen for MIBC
2
Ivermectin and Cancer: Navigating Patient Curiosity in Oncology Nursing
3
Creatine and Cancer Safety: Gabrielle Raucci Discusses Timing and Benefits
4
Dr. Oberstein on RASolute 302 and KRAS Breakthroughs in Pancreatic Cancer
5